Nichols & Pratt Advisers LLP Edwards Lifesciences Corp Transaction History
Nichols & Pratt Advisers LLP
- $1.5 Billion
- Q3 2024
A detailed history of Nichols & Pratt Advisers LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 5,050 shares of EW stock, worth $352,389. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,050
Previous 5,050
-0.0%
Holding current value
$352,389
Previous $466,000
28.54%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding EW
# of Institutions
1,350Shares Held
462MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.37 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.56 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.2 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.83 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$944 Million0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $43.1B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...